Binaytara
@binaytara.bsky.social
Advancing education, research, and innovation in hematology & oncology. #CancerPrevention #CancerAwareness #CancerSurvivors #CancerCare #HealthEquity #GlobalOncology #GlobalHealth #LGBTQ+🏳️🌈💙
Follow Us: https://buff.ly/MWm1IOU
Follow Us: https://buff.ly/MWm1IOU
Join Dr. Fengting Yan and Dr. Roland Walter at #WAHemBreast26 on Jan 17. Register TODAY: buff.ly/dhO9yho #Medsky #HemOnc #BreastCancer #CMEConference
January 2, 2026 at 9:26 PM
Join Dr. Fengting Yan and Dr. Roland Walter at #WAHemBreast26 on Jan 17. Register TODAY: buff.ly/dhO9yho #Medsky #HemOnc #BreastCancer #CMEConference
2x gifts end in mere hours❗This is your final chance to make an impact in 2025. All gifts made before midnight will be matched up to $5,000, doubling your impact to bring life-saving treatment, education, and dignity within reach. Give before midnight’s deadline: buff.ly/ZUobySy
December 31, 2025 at 11:01 PM
2x gifts end in mere hours❗This is your final chance to make an impact in 2025. All gifts made before midnight will be matched up to $5,000, doubling your impact to bring life-saving treatment, education, and dignity within reach. Give before midnight’s deadline: buff.ly/ZUobySy
The clock is ticking 🕓 Thousands are still waiting for essential cancer care. We are committed to providing access to compassionate care globally through hospitals, training, and research. Donate before midnight, and your contribution will be matched, doubling the impact: buff.ly/G1do6Je
December 31, 2025 at 4:04 PM
The clock is ticking 🕓 Thousands are still waiting for essential cancer care. We are committed to providing access to compassionate care globally through hospitals, training, and research. Donate before midnight, and your contribution will be matched, doubling the impact: buff.ly/G1do6Je
The countdown is on! Dr. Binay Shah and Tara Shah founded Binaytara to ensure dignified, high-quality cancer care for all. Now, you can help grow this vision. Double your donation by midnight tomorrow, matched up to $5,000, to support cancer care from Nepal to Seattle. Act now: buff.ly/WHct8XX
December 30, 2025 at 5:05 PM
The countdown is on! Dr. Binay Shah and Tara Shah founded Binaytara to ensure dignified, high-quality cancer care for all. Now, you can help grow this vision. Double your donation by midnight tomorrow, matched up to $5,000, to support cancer care from Nepal to Seattle. Act now: buff.ly/WHct8XX
From AI to mRNA vaccines, this year delivered breakthroughs that are reshaping how we detect, treat, and think about cancer. As innovation progresses, oncologists face challenges around equity, access, and implementing these advancements in real-world contexts: buff.ly/FHcGn0g #HemOnc
December 29, 2025 at 6:30 PM
From AI to mRNA vaccines, this year delivered breakthroughs that are reshaping how we detect, treat, and think about cancer. As innovation progresses, oncologists face challenges around equity, access, and implementing these advancements in real-world contexts: buff.ly/FHcGn0g #HemOnc
Reposted by Binaytara
Just returned from Janakpur, Nepal, feeling hopeful. Had a meaningful meeting with Rabindra Bohara (DG, DUDBC), alongside Hari Tiwari (Binaytara Nepal) and KU team.
We’re moving closer to final approvals for the @binaytara.bsky.social Cancer Hospital in Janakpur. #GlobalHealth #Nepal #Binaytara
We’re moving closer to final approvals for the @binaytara.bsky.social Cancer Hospital in Janakpur. #GlobalHealth #Nepal #Binaytara
December 28, 2025 at 5:55 PM
Just returned from Janakpur, Nepal, feeling hopeful. Had a meaningful meeting with Rabindra Bohara (DG, DUDBC), alongside Hari Tiwari (Binaytara Nepal) and KU team.
We’re moving closer to final approvals for the @binaytara.bsky.social Cancer Hospital in Janakpur. #GlobalHealth #Nepal #Binaytara
We’re moving closer to final approvals for the @binaytara.bsky.social Cancer Hospital in Janakpur. #GlobalHealth #Nepal #Binaytara
Across the globe, patients still await the cancer care they deserve. We’re committed to delivering high-quality care, training healthcare professionals, and fostering shared research. Through 12/31, every donation will be matched up to $5,000. Make your matched gift: buff.ly/38e98nT
Donate to Binaytara Hospital Campaign
Donate today to help build a comprehensive cancer hospital in Nepal.
buff.ly
December 28, 2025 at 5:03 PM
Across the globe, patients still await the cancer care they deserve. We’re committed to delivering high-quality care, training healthcare professionals, and fostering shared research. Through 12/31, every donation will be matched up to $5,000. Make your matched gift: buff.ly/38e98nT
From early-stage to metastatic disease, #SABCS 2025 delivered practice-changing insights. Read Dr. Milana Dolezal’s expert review of the most impactful trials shaping breast cancer care: buff.ly/jb5jtx6#Brea... #ClinicalTrial #CancerTreatment #CancerResearch #medsky
December 27, 2025 at 5:02 PM
From early-stage to metastatic disease, #SABCS 2025 delivered practice-changing insights. Read Dr. Milana Dolezal’s expert review of the most impactful trials shaping breast cancer care: buff.ly/jb5jtx6#Brea... #ClinicalTrial #CancerTreatment #CancerResearch #medsky
Access to cancer care often depends on location. We are working to change this by expanding hospital services, training providers, and educating rural communities. Donate to have your gift matched up to $5,000, doubling its impact for those most in need: buff.ly/dvO7hZ1
December 26, 2025 at 5:03 PM
Access to cancer care often depends on location. We are working to change this by expanding hospital services, training providers, and educating rural communities. Donate to have your gift matched up to $5,000, doubling its impact for those most in need: buff.ly/dvO7hZ1
As 2025 ends, we at Binaytara wish you peace, hope, and joy. This year, we've expanded cancer care and education from Nepal to Nigeria, creating opportunities for patients and providers worldwide. Thank you for believing that compassion knows no borders.
December 22, 2025 at 5:04 PM
As 2025 ends, we at Binaytara wish you peace, hope, and joy. This year, we've expanded cancer care and education from Nepal to Nigeria, creating opportunities for patients and providers worldwide. Thank you for believing that compassion knows no borders.
Does sugar really “feed” cancer, or is that an oversimplified myth? 🍬🧬We break down what science actually says about added vs natural sugars, insulin resistance, inflammation, and cancer risk—plus what it means for patients in treatment and survivorship: buff.ly/GdsFHxN #CancerCare #Mythbusting
December 19, 2025 at 6:11 PM
Does sugar really “feed” cancer, or is that an oversimplified myth? 🍬🧬We break down what science actually says about added vs natural sugars, insulin resistance, inflammation, and cancer risk—plus what it means for patients in treatment and survivorship: buff.ly/GdsFHxN #CancerCare #Mythbusting
A $40 gene-expression-based test could change how we diagnose and treat Philadelphia-like ALL in Asian patients. Dr. Dikshat Gupta’s work on the PHi-RACE classifier and CD36 overexpression is a powerful example of precision oncology meeting real-world affordability: buff.ly/mYFkaaR
December 18, 2025 at 5:31 PM
A $40 gene-expression-based test could change how we diagnose and treat Philadelphia-like ALL in Asian patients. Dr. Dikshat Gupta’s work on the PHi-RACE classifier and CD36 overexpression is a powerful example of precision oncology meeting real-world affordability: buff.ly/mYFkaaR
The Summit on Cancer Health Disparities 2026 has received a record 113 abstract submissions from 32 countries, highlighting global commitment to tackling cancer inequities. Learn what this milestone means for the future of equity-driven cancer care: buff.ly/WbU2Zx2#Medsky #HemOnc #HealthEquity
Summit on Cancer Health Disparities 2026 Sets Record for Global Abstract Submissions
The Summit on Cancer Health Disparities 2026 received 113 abstracts from 32 countries, underscoring global commitment to equity-focused cancer research and care.
buff.ly
December 17, 2025 at 9:54 PM
The Summit on Cancer Health Disparities 2026 has received a record 113 abstract submissions from 32 countries, highlighting global commitment to tackling cancer inequities. Learn what this milestone means for the future of equity-driven cancer care: buff.ly/WbU2Zx2#Medsky #HemOnc #HealthEquity
#mRNA cancer vaccines are moving from concept to clinic — and they’re not preventative, but personalized therapies designed to target each patient’s unique tumor. From Keynote-942 data in melanoma to the promise of “waking up” cold tumors, explore the top 8 takeaways: buff.ly/XxM30vy
December 17, 2025 at 6:10 PM
#mRNA cancer vaccines are moving from concept to clinic — and they’re not preventative, but personalized therapies designed to target each patient’s unique tumor. From Keynote-942 data in melanoma to the promise of “waking up” cold tumors, explore the top 8 takeaways: buff.ly/XxM30vy
Today, we celebrate our Founding Champions, the dedicated early supporters who believed in our mission before the first hospital was built. We’re honored to share their reflections from this year. Join us in building the future of cancer care by 2026 and beyond. Give now: buff.ly/BXyw9k0
December 16, 2025 at 5:05 PM
Today, we celebrate our Founding Champions, the dedicated early supporters who believed in our mission before the first hospital was built. We’re honored to share their reflections from this year. Join us in building the future of cancer care by 2026 and beyond. Give now: buff.ly/BXyw9k0
🚨 Final Call - Today is the deadline! Submit your abstract NOW: binaytara.org/research-gra... Share with fellows, early-career investigators, and colleagues who shouldn’t miss this opportunity. #CancerResearch #ResearchFunding
December 15, 2025 at 5:33 PM
🚨 Final Call - Today is the deadline! Submit your abstract NOW: binaytara.org/research-gra... Share with fellows, early-career investigators, and colleagues who shouldn’t miss this opportunity. #CancerResearch #ResearchFunding
The CME/MOC-accreditedBest of Hematology 2026 is coming to Albuquerque! Join Ala Ebaid, MD (UNM Health Sciences Center), Ethan Binder, MD (Presbyterian Health Systems), and other leading hematologists on Jan 31, 2026.🚨Reserve your spot today: buff.ly/dqMeLYJ#HemOnc #Medsky
December 13, 2025 at 4:01 PM
The CME/MOC-accreditedBest of Hematology 2026 is coming to Albuquerque! Join Ala Ebaid, MD (UNM Health Sciences Center), Ethan Binder, MD (Presbyterian Health Systems), and other leading hematologists on Jan 31, 2026.🚨Reserve your spot today: buff.ly/dqMeLYJ#HemOnc #Medsky
Reposted by Binaytara
Yesterday afternoon, our @binaytara.bsky.social family came together to celebrate the holidays! Fun, laughter, and festive cheer all around.
#BinaytaraFamily #HolidayJoy #TeamCelebration
#BinaytaraFamily #HolidayJoy #TeamCelebration
December 12, 2025 at 8:52 PM
Yesterday afternoon, our @binaytara.bsky.social family came together to celebrate the holidays! Fun, laughter, and festive cheer all around.
#BinaytaraFamily #HolidayJoy #TeamCelebration
#BinaytaraFamily #HolidayJoy #TeamCelebration
Cancer care isn’t equal everywhere, but how big are the disparities? Take a guess below and tell us your answer⬇️#GlobalHealth #Nonprofit #Binaytara #GlobalOncology
December 10, 2025 at 6:10 PM
Cancer care isn’t equal everywhere, but how big are the disparities? Take a guess below and tell us your answer⬇️#GlobalHealth #Nonprofit #Binaytara #GlobalOncology
The CME/MOC-accredited Best of Hematology and Breast Cancer 2026 is coming to #Houston! Join Shilpan Shah, MD (Houston Methodist Neal Cancer Center), Julie Nangia, MD (Baylor College of Medicine), and other leading oncologists from Jan 23-24, 2026.🚨Reserve your spot today: buff.ly/LsvGagt #HemOnc
December 10, 2025 at 4:01 PM
The CME/MOC-accredited Best of Hematology and Breast Cancer 2026 is coming to #Houston! Join Shilpan Shah, MD (Houston Methodist Neal Cancer Center), Julie Nangia, MD (Baylor College of Medicine), and other leading oncologists from Jan 23-24, 2026.🚨Reserve your spot today: buff.ly/LsvGagt #HemOnc
⏰ Less Than One Week Left! The deadline to submit your abstract for the $25,000 Implementation Science Research Awards from Binaytara is December 15. 🔗 Submit your abstract TODAY: buff.ly/S7GBqQz Help us spread the word by sharing with fellows and colleagues who should be applying! #HemOnc #Research
December 9, 2025 at 9:33 PM
⏰ Less Than One Week Left! The deadline to submit your abstract for the $25,000 Implementation Science Research Awards from Binaytara is December 15. 🔗 Submit your abstract TODAY: buff.ly/S7GBqQz Help us spread the word by sharing with fellows and colleagues who should be applying! #HemOnc #Research
Join Deepti Behl, MD (Mayo Clinic), Dron Gauchan, MD (Sutter Medical Group), and other leading oncologists at the CME/MOC-accredited 2026 Northern California Hematology Oncology Conference from Jan 23-24, 2026. Register today: buff.ly/M4MECdE #Medsky #HemOnc
December 8, 2025 at 9:45 PM
Join Deepti Behl, MD (Mayo Clinic), Dron Gauchan, MD (Sutter Medical Group), and other leading oncologists at the CME/MOC-accredited 2026 Northern California Hematology Oncology Conference from Jan 23-24, 2026. Register today: buff.ly/M4MECdE #Medsky #HemOnc
This Giving Tuesday, we felt your support more than ever. Together, we’re expanding access to cancer care where it’s needed most. Thank you for standing with us in 2025! Here’s to more life-changing impact in the year ahead.
December 7, 2025 at 5:01 PM
This Giving Tuesday, we felt your support more than ever. Together, we’re expanding access to cancer care where it’s needed most. Thank you for standing with us in 2025! Here’s to more life-changing impact in the year ahead.
The CME/MOC-accredited Best of Hematology and Breast Cancer 2026 is happening in Seattle! Join Dr. Fengting Yan (Swedish Cancer Institute), Roland Walter, MD (Fred Hutch Cancer Center), and other leading oncologists on Jan 17, 2026. Register today: buff.ly/aG1XG6Q #Medsky #HemOnc
December 5, 2025 at 7:26 PM
The CME/MOC-accredited Best of Hematology and Breast Cancer 2026 is happening in Seattle! Join Dr. Fengting Yan (Swedish Cancer Institute), Roland Walter, MD (Fred Hutch Cancer Center), and other leading oncologists on Jan 17, 2026. Register today: buff.ly/aG1XG6Q #Medsky #HemOnc
Targeted therapies and biomarkers are here. Dr. Shivaani Kummar explores why adoption lags behind science and how better trial design, dose optimization, AI-driven biomarkers, and cancer interception could reshape the next era of oncology: buff.ly/qeMaOkV
December 5, 2025 at 6:01 PM
Targeted therapies and biomarkers are here. Dr. Shivaani Kummar explores why adoption lags behind science and how better trial design, dose optimization, AI-driven biomarkers, and cancer interception could reshape the next era of oncology: buff.ly/qeMaOkV